Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018433810> ?p ?o ?g. }
Showing items 1 to 91 of
91
with 100 items per page.
- W2018433810 endingPage "e110681" @default.
- W2018433810 startingPage "e110681" @default.
- W2018433810 abstract "Patients with primary membranous nephropathy (MN) who experience spontaneous remission of proteinuria generally have an excellent outcome without need of immunosuppressive therapy. It is, however, unclear whether non-nephrotic proteinuria at the time of diagnosis is also associated with good prognosis since a reasonable number of these patients develop nephrotic syndrome despite blockade of the renin-angiotensin system. No clinical or laboratory parameters are available, which allow the assessment of risk for development of nephrotic proteinuria. Phospholipase A2 Receptor antibodies (PLA2R-Ab) play a prominent role in the pathogenesis of primary MN and are associated with persistence of nephrotic proteinuria. In this study we analysed whether PLA2R-Ab levels might predict development of nephrotic syndrome and the clinical outcome in 33 patients with biopsy-proven primary MN and non-nephrotic proteinuria under treatment with blockers of the renin-angiotensin system. PLA2R-Ab levels, proteinuria and serum creatinine were measured every three months. Nephrotic-range proteinuria developed in 18 (55%) patients. At study start (1.2±1.5 months after renal biopsy and time of diagnosis), 16 (48%) patients were positive for PLA2R-Ab. A multivariate analysis showed that PLA2R-Ab levels were associated with an increased risk for development of nephrotic proteinuria (HR = 3.66; 95%CI: 1.39–9.64; p = 0.009). Immunosuppressive therapy was initiated more frequently in PLA2R-Ab positive patients (13 of 16 patients, 81%) compared to PLA2R-Ab negative patients (2 of 17 patients, 12%). PLA2R-Ab levels are associated with higher risk for development of nephrotic-range proteinuria in this cohort of non-nephrotic patients at the time of diagnosis and should be closely monitored in the clinical management." @default.
- W2018433810 created "2016-06-24" @default.
- W2018433810 creator A5002634924 @default.
- W2018433810 creator A5040494349 @default.
- W2018433810 creator A5045693974 @default.
- W2018433810 creator A5072008904 @default.
- W2018433810 creator A5081376870 @default.
- W2018433810 date "2014-10-14" @default.
- W2018433810 modified "2023-09-30" @default.
- W2018433810 title "PLA2R Antibody Levels and Clinical Outcome in Patients with Membranous Nephropathy and Non-Nephrotic Range Proteinuria under Treatment with Inhibitors of the Renin-Angiotensin System" @default.
- W2018433810 cites W2005989846 @default.
- W2018433810 cites W2034759249 @default.
- W2018433810 cites W2038390766 @default.
- W2018433810 cites W2095787590 @default.
- W2018433810 cites W2097148864 @default.
- W2018433810 cites W2104270462 @default.
- W2018433810 cites W2115472834 @default.
- W2018433810 cites W2116177442 @default.
- W2018433810 cites W2133344401 @default.
- W2018433810 cites W2140565611 @default.
- W2018433810 cites W2157296439 @default.
- W2018433810 cites W2166822765 @default.
- W2018433810 doi "https://doi.org/10.1371/journal.pone.0110681" @default.
- W2018433810 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4197007" @default.
- W2018433810 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25313791" @default.
- W2018433810 hasPublicationYear "2014" @default.
- W2018433810 type Work @default.
- W2018433810 sameAs 2018433810 @default.
- W2018433810 citedByCount "89" @default.
- W2018433810 countsByYear W20184338102015 @default.
- W2018433810 countsByYear W20184338102016 @default.
- W2018433810 countsByYear W20184338102017 @default.
- W2018433810 countsByYear W20184338102018 @default.
- W2018433810 countsByYear W20184338102019 @default.
- W2018433810 countsByYear W20184338102020 @default.
- W2018433810 countsByYear W20184338102021 @default.
- W2018433810 countsByYear W20184338102022 @default.
- W2018433810 countsByYear W20184338102023 @default.
- W2018433810 crossrefType "journal-article" @default.
- W2018433810 hasAuthorship W2018433810A5002634924 @default.
- W2018433810 hasAuthorship W2018433810A5040494349 @default.
- W2018433810 hasAuthorship W2018433810A5045693974 @default.
- W2018433810 hasAuthorship W2018433810A5072008904 @default.
- W2018433810 hasAuthorship W2018433810A5081376870 @default.
- W2018433810 hasBestOaLocation W20184338101 @default.
- W2018433810 hasConcept C126322002 @default.
- W2018433810 hasConcept C134018914 @default.
- W2018433810 hasConcept C159641895 @default.
- W2018433810 hasConcept C2775946357 @default.
- W2018433810 hasConcept C2778930706 @default.
- W2018433810 hasConcept C2779561371 @default.
- W2018433810 hasConcept C2780091579 @default.
- W2018433810 hasConcept C2780368995 @default.
- W2018433810 hasConcept C2781087799 @default.
- W2018433810 hasConcept C71924100 @default.
- W2018433810 hasConcept C90924648 @default.
- W2018433810 hasConceptScore W2018433810C126322002 @default.
- W2018433810 hasConceptScore W2018433810C134018914 @default.
- W2018433810 hasConceptScore W2018433810C159641895 @default.
- W2018433810 hasConceptScore W2018433810C2775946357 @default.
- W2018433810 hasConceptScore W2018433810C2778930706 @default.
- W2018433810 hasConceptScore W2018433810C2779561371 @default.
- W2018433810 hasConceptScore W2018433810C2780091579 @default.
- W2018433810 hasConceptScore W2018433810C2780368995 @default.
- W2018433810 hasConceptScore W2018433810C2781087799 @default.
- W2018433810 hasConceptScore W2018433810C71924100 @default.
- W2018433810 hasConceptScore W2018433810C90924648 @default.
- W2018433810 hasIssue "10" @default.
- W2018433810 hasLocation W20184338101 @default.
- W2018433810 hasLocation W20184338102 @default.
- W2018433810 hasLocation W20184338103 @default.
- W2018433810 hasLocation W20184338104 @default.
- W2018433810 hasOpenAccess W2018433810 @default.
- W2018433810 hasPrimaryLocation W20184338101 @default.
- W2018433810 hasRelatedWork W1969302926 @default.
- W2018433810 hasRelatedWork W2018433810 @default.
- W2018433810 hasRelatedWork W2255097837 @default.
- W2018433810 hasRelatedWork W2617482626 @default.
- W2018433810 hasRelatedWork W3022896292 @default.
- W2018433810 hasRelatedWork W4229038821 @default.
- W2018433810 hasRelatedWork W4296373815 @default.
- W2018433810 hasRelatedWork W4300513650 @default.
- W2018433810 hasRelatedWork W4380447838 @default.
- W2018433810 hasRelatedWork W90396326 @default.
- W2018433810 hasVolume "9" @default.
- W2018433810 isParatext "false" @default.
- W2018433810 isRetracted "false" @default.
- W2018433810 magId "2018433810" @default.
- W2018433810 workType "article" @default.